Clinical Trial: Identification of BCR::ABL1 Mutations by Digital PCR in CML

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07158294) titled 'Identification of BCR::ABL1 Mutations by Digital PCR in CML' on Aug. 28.

Brief Summary: The goal of this study is to asses the ability of digital PCR (ddPCR) to detect actionable mutations in adult CML patients with failure of TKI therapy. The main objective of the study is it aims to answer is to assess whether ddPCR is at least as effective as NGS in detecting actionable (2GTKI-resistant) mutations.

To accomplish this aim, samples of participants treated according to clinical practice, will be taken and analyzed for the presence of BCR::ABL1 KD mutations by ddPCR.

Study Start Date: Feb. 01, 2026

Study Type: INTERVENTIONAL

Cond...